Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Clinical Trials Search

As a clinical trial candidate at Methodist, you’re offered unique access to new drugs and technology being studied to improve patient outcomes.
Filter by Disease or Condition
Showing 11-20 results of 79
Breast Cancer

Alliance A011801

Official Title: T-DM1 and Tucatinib Compared With T-DM1 Alone In Preventing Relapses In People With High Risk Her2-Positive Breast Cancer
Study Purpose: To compare the usual treatment with T-DM1 alone to T-DM1 plus tucatinib.
Status: Recruiting
Gastrointestinal Cancer

Alliance A021806

Official Title: Testing The Use Of The Usual Chemotherapy Before And After Surgery For Removable Pancreatic Cancer
Study Purpose: To determine if receiving chemotherapy before and after surgery will increase the chance of pancreatic cancer staying away.
Status: Recruiting
Urinary Cancer

Alliance A031702

Official Title: Testing the effectiveness of two immunotherapy drugs (nivolumab and ipilimumab) with one anti-cancer targeted drug (cabozantinib) for rare genitourinary tumors
Study Purpose: To test the good and bad effects of the drugs cabozantinib, nivolumab, and ipilimumab in rare genitourinary cancers that have no standard treatment options. The doctors hope to learn if the study drugs will stabilize or shrink the cancer.
Status: Recruiting
Urinary Cancer

Alliance A031704

Official Title: Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab with Cabozantinib for Patients with Advanced Kidney Cancer
Study Purpose: To see how well nivolumab and ipilimumab, followed by nivolumab versus cabozantinib and nivolumab, work in treating renal cell cancer that is untreated and has spread to other parts of the body.
Status: Recruiting
Blood Cancer

Alliance A041701

Official Title: A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Study Purpose: To compare the usual treatment alone to using uproleselan plus the usual treatment.
Status: Suspended
Lung Cancer

Alliance A081801

Official Title: Testing The Addition Of A Type Of Drug Called Immunotherapy To The Usual Chemotherapy Treatment For Non-Small Cell Lung Cancer
Study Purpose: To compare the usual treatment alone to using pembrolizumab plus the usual treatment.  The addition of pembrolizumab to the usual treatment could prevent it from returning.
Status: Recruiting
Lung Cancer

Alliance A151216

Official Title: Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Study Purpose: To study the genes of tumor cells to determine if these results will help physicians select the best treatment options for patients with genetic changes. 
Status: Recruiting
Gastrointestinal Cancer

Alliance A221805

Official Title: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blinded Placebo-Controlled Phase II to Phase III Study.
Study Purpose: To determine if duloxetine prevent numbness, tingling, and/or pain caused by your cancer treatment with oxaliplatin.
Status: Recruiting
Breast Cancer

BCCR BREAST CANCER REGISTRY

Official Title:  Breast Cancer Registry
Study Purpose: BCCR is a unique resource for the collection and management of cancer and health-related data.
Status: Recruiting
Rare Tumor

BO41932

Official Title: TUMOR-AGNOSTIC PRECISION IMMUNO-ONCOLOGY AND SOMATIC TARGETING RATIONAL FOR YOU (TAPISTRY) PHASE II PLATFORM TRIAL
Study Purpose: To explore a diverse range of both investigational and off-label FDA-approved drugs, each targeting a unique mutation.
Status: Recruiting